A Trial of HHPG-19K Injection and Auto-HHPG-19K Injection in Prevention of Chemotherapy-related Moderate to Severe Neutropenia of Patients With Nonmyeloid Malignancies

Clinical trial NCT06254742 · WITHDRAWN

Trial details

NCT number: NCT06254742
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Patients With Nonmyeloid Malignancies Receiving Antineoplastic Therapy Based on Chemotherapy Regimens at Moderate to High Febrile Neutropenia (FN) Risk

Start date: 2024-02-01
Primary completion: 2025-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.